Offer - Urjas Oil for just Rs 1 X
Adrole 0.25 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Parkinson's Disease, Restless Legs Syndrome. Adrole 0.25 Tablet also has some secondary and off-label uses. These are listed below.
The optimal dosage of Adrole 0.25 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Adrole 0.25 Tablet also has some side effects, the most common being Sleepiness, Weakness, Influenza like symptoms. Besides the aforementioned side effects, there are other adverse effects of Adrole 0.25 Tablet as well, which are listed below. Normally, these side effects of Adrole 0.25 Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Adrole 0.25 Tablet has a Moderate effect for pregnant women and Severe effect on lactating mothers. Warnings related to Adrole 0.25 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Adrole 0.25 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Adrole 0.25 Tablet in conditions like Low Blood Pressure (Hypotension), Psychosis. Other contraindications of Adrole 0.25 Tablet have been discussed in the sections ahead.
Drug interactions for Adrole 0.25 Tablet have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Adrole 0.25 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Adrole 0.25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Adrole 0.25 Tablet safe for pregnant women?
Adrole can have harmful effects in pregnant women. If you experience any discomfort after using Adrole, then discontinue the use and take your doctor's advice.
Is the use of Adrole 0.25 Tablet safe during breastfeeding?
Adrole should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Adrole 0.25 Tablet on the Kidneys?
Adrole rarely affects the kidneys.
What is the effect of Adrole 0.25 Tablet on the Liver?
Side effects of Adrole rarely affect the liver.
What is the effect of Adrole 0.25 Tablet on the Heart?
Side effects of Adrole rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Adrole 0.25 Tablet unless your doctor advises you to do so -
Is this Adrole 0.25 Tablet habit forming or addictive?
Adrole 0.25 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Adrole 0.25 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Adrole 0.25 Tablet only on doctor's advice.
Is it able to treat mental disorders?
Yes, Adrole 0.25 Tablet is useful in treating mental disorders.
Interaction between Food and Adrole 0.25 Tablet
Eating certain foods may increase the time it takes Adrole 0.25 Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Adrole 0.25 Tablet
Consumption of alcohol and Adrole 0.25 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Requip (ropinirole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 430-431
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1114-1116